According to SPER Market Research, the Aptamers Market estimated to reach USD 592 million by 2030 with a CAGR of 16.4%. Aptamers are oligonucleotide molecules, which bind to a particular target molecule.
Aptamers are short, single-stranded DNA, RNA, or synthetic XNA molecules, which bind to a specific target molecule. They are used to facilitate discoveries in basic research, ensure food safety and environment monitoring.
Due to prevalence of chronic diseases worldwide, there comes aptamers based therapeutic and diagnostic treatment.
The record breaking number of clinical trials, and awareness about the pros of aptamers than antibodies, growing investment in R&D, and aptamers-based therapeutics and diagnostics; are the fuel for the growth of aptamers market.
Increase in the funding for research on aptamers, collaboration of research centres and Pharma companies, creates huge opportunities in this market.
Lacks of skilled personnel, skilled technician, low market approval, less acceptance by the scientific community are the challenges for the growth of this market.
In the aptamers type market; the DNA-based aptamers segment and aptamers application market; the therapeutics development segment is going to dominate.
The increase in the investment on R & D, drug discovery and development are the key factors for the growth of this market in Asia Pacific.
The biggest share of Aptamers Market is with North America. This is due to the existence of top market players, accessibility of funds for innovative techniques.
The global Aptamers Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Aptamer Group, Aptamer Sciences, Inc. Aptagen, LLC, Raptamer Discovery Group, SomaLogic Inc.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product segment- DNA Aptamers, XNA Aptamers, RNA Aptamers, Application segment- Therapeutics Development, Research & Development, Diagnostic, Others.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.